A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection-Reference-Cited by-同舟云学术

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection

Published:2020-09 Issue:3 Volume:6 Page:100004
ISSN:2055-6640
Container-title:Journal of Virus Eradication
language:en
Short-container-title:Journal of Virus Eradication

Author:

Kroon Eugène D.M.B.,Ananworanich Jintanat,Pagliuzza Amélie,Rhodes Ajantha,Phanuphak Nittaya^ORCID,Trautmann Lydie^ORCID,Mitchell Julie L.,Chintanaphol Michelle^ORCID,Intasan Jintana,Pinyakorn Suteeraporn,Benjapornpong Khuntalee,Chang J. Judy^ORCID,Colby Donn J.^ORCID,Chomchey Nitiya,Fletcher James L.K.,Eubanks Keith,Yang Hua,Kapson John^ORCID,Dantanarayana Ashanti,Tennakoon Surekha,Gorelick Robert J.,Maldarelli Frank^ORCID,Robb Merlin L.,Kim Jerome H.,Spudich Serena,Chomont Nicolas^ORCID,Phanuphak Praphan,Lewin Sharon R.,de Souza Mark S.^ORCID

Funder

Henry M Jackson Foundation for the Advancement of Military Medicine, Inc.

US Department of the Army

Thai Red Cross AIDS Research Centre

the National Institute of Neurologic Disorders and Stroke

National Cancer Institute

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Health and Medical Research Council of Australia

NHMRC Program

National Institutes for Health Delaney AIDS Research Enterprise

Cooper Human Systems, Nashua, NH, USA